Keyword Index

A

  • Acute lymphoblastic leukemia High CRLF2 Expression Could Identify Acute Lymphoblastic Leukemia Patients with Poor Outcome but Not IKZF1 [Volume 17, Issue 1, 2021, Pages 23-30]
  • Acute lymphoblastic leukemia First Relapse of Acute Lymphoblastic Leukemia in Children in Upper Egypt: Survival Outcome and Prognostic Factors [Volume 17, Issue 2, 2021, Pages 51-59]
  • Awareness Breast Cancer Awareness among Egyptian Women and the Impact of Caring for Patients with Breast Cancer on Family Caregivers’ Knowledge and Behaviour [Volume 17, Issue 1, 2021, Pages 1-8]

B

  • Body Mass Index Interleukin-10 -1082 A/G Promoter Polymorphism in Newly Diagnosed Gastro-Intestinal Malignancies and Its Relation to the Nutritional and Performance Status [Volume 17, Issue 1, 2021, Pages 17-22]

C

  • Cancer Interleukin-10 -1082 A/G Promoter Polymorphism in Newly Diagnosed Gastro-Intestinal Malignancies and Its Relation to the Nutritional and Performance Status [Volume 17, Issue 1, 2021, Pages 17-22]
  • Chronic lymphocytic leukemia COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia: Report of Two Cases and Literature Review [Volume 17, Issue 2, 2021, Pages 80-85]
  • Cisplatin Study of the Efficacy and Multidrug Resistance Using Gold Nanoparticles-Based Drug Delivery Versus Conventional Chemotherapy in Non-Small-Cell Lung Cancer Cell Line [Volume 17, Issue 2, 2021, Pages 42-50]
  • Complications Impact of Steroid-Induced Diabetes on Prognosis of Patients with Aggressive Lymphoid Malignancies: A Prospective Study [Volume 17, Issue 1, 2021, Pages 31-37]
  • COVID-19 COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia: Report of Two Cases and Literature Review [Volume 17, Issue 2, 2021, Pages 80-85]
  • Cytokine receptor-like factor 2 High CRLF2 Expression Could Identify Acute Lymphoblastic Leukemia Patients with Poor Outcome but Not IKZF1 [Volume 17, Issue 1, 2021, Pages 23-30]
  • Cytokines Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma [Volume 17, Issue 1, 2021, Pages 38-41]
  • Cytokines Interleukin-10 -1082 A/G Promoter Polymorphism in Newly Diagnosed Gastro-Intestinal Malignancies and Its Relation to the Nutritional and Performance Status [Volume 17, Issue 1, 2021, Pages 17-22]

E

  • Egypt Breast Cancer Awareness among Egyptian Women and the Impact of Caring for Patients with Breast Cancer on Family Caregivers’ Knowledge and Behaviour [Volume 17, Issue 1, 2021, Pages 1-8]
  • Egypt Factors Influencing the Response Rate and Survival of Testicular Germ Cell Tumors: A Single Institution Experience from Egypt [Volume 17, Issue 2, 2021, Pages 66-72]
  • Egypt First Relapse of Acute Lymphoblastic Leukemia in Children in Upper Egypt: Survival Outcome and Prognostic Factors [Volume 17, Issue 2, 2021, Pages 51-59]

F

  • First relapse First Relapse of Acute Lymphoblastic Leukemia in Children in Upper Egypt: Survival Outcome and Prognostic Factors [Volume 17, Issue 2, 2021, Pages 51-59]

G

  • Gastrointestinal Stromal Tumor Gastrointestinal Stromal Tumor: Clinicopathological Features, Management, and Comparison of Three Risk Stratification Schemes [Volume 17, Issue 2, 2021, Pages 73-79]
  • Gemcitabine Study of the Efficacy and Multidrug Resistance Using Gold Nanoparticles-Based Drug Delivery Versus Conventional Chemotherapy in Non-Small-Cell Lung Cancer Cell Line [Volume 17, Issue 2, 2021, Pages 42-50]

H

  • HER2 EGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value [Volume 17, Issue 1, 2021, Pages 9-16]
  • High-grade EGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value [Volume 17, Issue 1, 2021, Pages 9-16]

I

  • IKZF 1 High CRLF2 Expression Could Identify Acute Lymphoblastic Leukemia Patients with Poor Outcome but Not IKZF1 [Volume 17, Issue 1, 2021, Pages 23-30]
  • IL-10 polymorphism Interleukin-10 -1082 A/G Promoter Polymorphism in Newly Diagnosed Gastro-Intestinal Malignancies and Its Relation to the Nutritional and Performance Status [Volume 17, Issue 1, 2021, Pages 17-22]
  • Interleukin−10 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma [Volume 17, Issue 1, 2021, Pages 38-41]

L

  • Lymphoid malignancies Impact of Steroid-Induced Diabetes on Prognosis of Patients with Aggressive Lymphoid Malignancies: A Prospective Study [Volume 17, Issue 1, 2021, Pages 31-37]

M

  • Management Gastrointestinal Stromal Tumor: Clinicopathological Features, Management, and Comparison of Three Risk Stratification Schemes [Volume 17, Issue 2, 2021, Pages 73-79]
  • Multiple myeloma Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma [Volume 17, Issue 1, 2021, Pages 38-41]

N

  • Nanoparticles Study of the Efficacy and Multidrug Resistance Using Gold Nanoparticles-Based Drug Delivery Versus Conventional Chemotherapy in Non-Small-Cell Lung Cancer Cell Line [Volume 17, Issue 2, 2021, Pages 42-50]
  • Neoadjuvant chemotherapy Evaluation of Sentinel Lymph Node Biopsy After Primary Chemotherapy as Part of De-Escalation of Breast Cancer Treatment [Volume 17, Issue 2, 2021, Pages 60-65]
  • Non-Small Cell Lung Cancer Study of the Efficacy and Multidrug Resistance Using Gold Nanoparticles-Based Drug Delivery Versus Conventional Chemotherapy in Non-Small-Cell Lung Cancer Cell Line [Volume 17, Issue 2, 2021, Pages 42-50]

O

  • Ovarian EGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value [Volume 17, Issue 1, 2021, Pages 9-16]

P

  • Patent blue dye Evaluation of Sentinel Lymph Node Biopsy After Primary Chemotherapy as Part of De-Escalation of Breast Cancer Treatment [Volume 17, Issue 2, 2021, Pages 60-65]
  • Performance status Interleukin-10 -1082 A/G Promoter Polymorphism in Newly Diagnosed Gastro-Intestinal Malignancies and Its Relation to the Nutritional and Performance Status [Volume 17, Issue 1, 2021, Pages 17-22]
  • Prognostic factors First Relapse of Acute Lymphoblastic Leukemia in Children in Upper Egypt: Survival Outcome and Prognostic Factors [Volume 17, Issue 2, 2021, Pages 51-59]

S

  • SARS-CoV-2 COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia: Report of Two Cases and Literature Review [Volume 17, Issue 2, 2021, Pages 80-85]
  • Screening Breast Cancer Awareness among Egyptian Women and the Impact of Caring for Patients with Breast Cancer on Family Caregivers’ Knowledge and Behaviour [Volume 17, Issue 1, 2021, Pages 1-8]
  • Serous Carcinoma EGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value [Volume 17, Issue 1, 2021, Pages 9-16]
  • Survival First Relapse of Acute Lymphoblastic Leukemia in Children in Upper Egypt: Survival Outcome and Prognostic Factors [Volume 17, Issue 2, 2021, Pages 51-59]

T

  • Testicular germ cell tumors Factors Influencing the Response Rate and Survival of Testicular Germ Cell Tumors: A Single Institution Experience from Egypt [Volume 17, Issue 2, 2021, Pages 66-72]
  • Treatment Factors Influencing the Response Rate and Survival of Testicular Germ Cell Tumors: A Single Institution Experience from Egypt [Volume 17, Issue 2, 2021, Pages 66-72]
  • Tumor burden Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma [Volume 17, Issue 1, 2021, Pages 38-41]